Trastorno Neurocognitivo Leve: una revisión del estado del arte
Archivos
NO SE HA AUTORIZADO la consulta de los documentos asociados
Fecha
2023-01-13
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Resumen
(ES) El deterioro cognitivo hace referencia a la etapa temprana de pérdida de capacidad cognitiva en personas que
tienen la capacidad de realizar de forma independiente la mayoría de las actividades de la vida diaria. Es
una etapa de transición entre el envejecimiento normal y el envejecimiento patológico con una etiología
multicausal. La división del Deterioro Cognitivo Leve en subtipos es muy valiosa para diferenciar el
riesgo de desarrollar distintos tipos de demencia y que se clasifican en amnésico puro, multidominio o
no amnésico. Se ha llevado a cabo una revisión en torno al perfil neuropsicológico, criterios diagnósticos,
marcadores y factores específicos, tratamientos y pruebas de evaluación con el fin de proporcionar un
marco general sobre el Trastorno Neurocognitivo Leve. Es fundamental una evaluación para detectar de
manera temprana posibles alteraciones y adoptar medidas que enlentecen el deterioro.
(EN) Cognitive impairment refers to the early stage of loss cognitive ability in people who have the ability to independently perform most activities of daily life. It is a transition stage between normal and pathological aging with various causes etiology. The division of cognitive impairment in subtypes is very important to differentiate the risk of developing different types of dementia and it is classified as pure amnesic, multidomain, and non-amnesic. A review has been carried out on neuropsychological profile, diagnostic criteria, indicator and specific factor, pharmacologist treatment and therapy, evaluation test with aim of provide a general structural about mild neurocognitive disorder. It is fundamental the evaluation of detect possible alterations early and adopt steps which reduces the impairment.
(EN) Cognitive impairment refers to the early stage of loss cognitive ability in people who have the ability to independently perform most activities of daily life. It is a transition stage between normal and pathological aging with various causes etiology. The division of cognitive impairment in subtypes is very important to differentiate the risk of developing different types of dementia and it is classified as pure amnesic, multidomain, and non-amnesic. A review has been carried out on neuropsychological profile, diagnostic criteria, indicator and specific factor, pharmacologist treatment and therapy, evaluation test with aim of provide a general structural about mild neurocognitive disorder. It is fundamental the evaluation of detect possible alterations early and adopt steps which reduces the impairment.